Louise Davies, MD, MS, an associate professor of surgery and of The Dartmouth Institute, is one of two Dartmouth faculty to have been named Fulbright Scholars for the 2017-2018 academic year, enabling their planned teaching and research activities abroad.
Konstantin Dragnev, MD, a practicing oncologist at the Dartmouth-Hitchcock Norris Cotton Cancer Center and a translational scientist, has been named the Irene Heinz Given Professor in Pharmacology.
A new Dartmouth study shows that travel time is not a deterrent to radiation therapy for treatment of prostate cancer in New Hampshire.
Arminja Kettenbach, PhD, an assistant professor of Biochemistry and Cell Biology at Geisel, recently received two high-profile grant awards to support her research in proteomics, which is shedding new light on what goes wrong in cell division during cancer.
Research published in the journal Nature Communications describes distribution of a DNA defect in the glioblastoma genome and its relationship with patient survival.
Giovanni Bosco, PhD, a professor of Molecular and Systems Biology, has been appointed to the Oscar M. Cohn 1934 Professorship.
Randolph Noelle, PhD, Professor of Microbiology and Immunology, has been named the inaugural holder of the Thomas S. Kosasa, MD, Professorship at the Geisel School of Medicine at Dartmouth.
While focusing on different populations as Robert Wood Johnson Foundation Clinical Scholars, Geisel alums Anita Arora and Carolyn Presley are both working toward the common goal of improving health care delivery.
A research team at The Dartmouth Institute for Health Policy and Clinical Practice has received a $2 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to conduct a research project that is likely to change the way women and their doctors make decisions about breast cancer surgery.
A new Dartmouth-led study has found that drinking water from private wells, particularly dug wells established during the first half of the 20th century, may have contributed to the elevated risk of bladder cancer that has been observed in Maine, New Hampshire, and Vermont for over 50 years.